The Food and Drug Administration fully approved Moderna's mRNA COVID-19 vaccine on Monday, saying it meets its safety and manufacturing requirements. Moderna's vaccine, which will now be marketed as Spikevax, is the second coronavirus vaccine to receive full approval after the FDA approved Pfizer-BioNTech's vaccine in August.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
